Journal Article Summary

The article investigates the formulation of an oral lyophilizate using cetirizine dihydrochloride (CTZ) as the active ingredient. This study is significant because oral lyophilizates combine the benefits of solid and liquid forms, making them easier to swallow and suitable for various patient populations, including children and the elderly. The research aims to optimize the formulation by examining the stability and characteristics of CTZ when combined with specific excipients, particularly mannitol and polyvinylpyrrolidone (PVP K30).

The researchers conducted a series of experiments to determine the best combination of excipients for the CTZ formulation. They utilized various analytical techniques, including powder x-ray diffraction and differential scanning calorimetry, to assess the stability and properties of CTZ in solid form. The findings revealed that while mannitol alone could lead to unstable forms, the addition of PVP K30 effectively prevented these metastable forms, resulting in a more stable and consistent oral lyophilizate. Ultimately, a formulation with 4.5% mannitol and 5% PVP K30 was identified as optimal for creating a stable and effective product.

Despite the promising results, the study has limitations, including the fixed freeze-drying cycle used, which may not allow for adjustments that could enhance the formulation further. Patients and caregivers should discuss the implications of this research with healthcare professionals, particularly regarding the use of cetirizine in oral lyophilizate form and any potential effects on treatment outcomes. Understanding the formulation's stability and characteristics can help ensure safe and effective use in clinical settings.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Flórez Borges Paloma, García-Montoya Encarna, Pérez-Lozano Pilar, Jo Enric, Miñarro Montserrat, Manich Albert, Suñé-Negre Josep Maria. The role of SeDeM for characterizing the active substance and polyvinyilpyrrolidone eliminating metastable forms in an oral lyophilizate—A preformulation study. PLoS ONE 2018. DOI: 10.1371/journal.pone.0196049. PMID: 29689061. PMCID: PMC5916852.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]